The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
From Pathophysiology to Novel Antidepressant Drugs: Glial Contributions to the Pathology and Treatment of Mood Disorders
Open accessAbstract
Several structural and cellular changes, including marked glial anomalies, have been observed in association with major depressive disorder. Here we review these cellular alterations and highlight the importance of glial cell pathology, especially astroglial dysfunction, in the pathophysiology of neuropsychiatric disorders with a particular interest in major depressive disorder. The functional role of astrocytes in glutamate uptake and glutamate/glutamine cycling is discussed, as is the deleterious effects of chronic stress on glial cell function. Lastly, we discuss the effect of antidepressants on glial cell function and the possibility of targeting glial cells in the quest to develop novel therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several human postmortem studies have also shown reductions in the expression of several components critical to astrocyte function, largely in the mPFC, but also some evidence in the hippocampus, suggesting impaired glutamate-glutamine cycling (133).”
From The Impact of Stress and Major Depressive Disorder on Hippocampal and Medial Prefrontal Cortex Morphology (2019) · cites this paper as [133]
In the citing paper
“There is also emerging evidence of impaired glutamate-glutamine cycling in the mPFC and hippocampus amongst those with MDD.”
From The Impact of Stress and Major Depressive Disorder on Hippocampal and Medial Prefrontal Cortex Morphology (2019) · cites this paper as [133]
In the citing paper
“Subjects with depression have been shown to display a variety of glutamatergic abnormalities, including reduced glial density, decreased expression of the glutamate reuptake transporters EAAT1 and EAAT2 and decreased enzymatic conversion from glutamate to glutamine [33].”
From Pharmacotherapies Targeting GABA-Glutamate Neurotransmission for Treatment-Resistant Depression (2023) · cites this paper as [33]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,526
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
Yatham, L. N., & Malhi, G. S. (2011) · Oxford University Press eBooks · doi:10.1093/med/9780199562305.001.0001 · Cited by 3,515
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Li, N., Lee, B., Liu, R.-J., Banasr, M., Dwyer, J. M., Iwata, M., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2010) · Science · doi:10.1126/science.1190287 · Cited by 2,881
Self-citationSynaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders
Hardingham, G. E., & Bading, H. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2911 · Cited by 1,644 · cited 1×
“Excessive activation of extrasynaptic to synaptic NMDA receptors has been linked to various forms of excitotoxicity, and has been implemented in the pathophysiology of multiple neurodegenerative disorders (57).”
BackgroundGlial reduction in the subgenual prefrontal cortex in mood disorders
Öngür, D., Drevets, W. C., & Price, J. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13290 · Cited by 1,525
β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression
Rothstein, J. D., Patel, S., Regan, M. R., Haenggeli, C., Huang, Y. H., Bergles, D. E., Jin, L., Dykes Hoberg, M., Vidensky, S., Chung, D. S., et al. (2005) · Nature · doi:10.1038/nature03180 · Cited by 1,518
Uniquely Hominid Features of Adult Human Astrocytes
Oberheim, N. A., Takano, T., Han, X., He, W., Lin, J. H. C., Wang, F., Xu, Q., Wyatt, J. D., Pilcher, W., Ojemann, J. G., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4707-08.2009 · Cited by 1,488
Rajkowska, G., Miguel-Hidalgo, J. J., Wei, J., Dilley, G., Pittman, S. D., Meltzer, H. Y., Overholser, J. C., Roth, B. L., & Stockmeier, C. A. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00041-4 · Cited by 1,477
Repertoire of microglial and macrophage responses after spinal cord injury
David, S., & Kroner, A. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3053 · Cited by 1,297
Flagged first, then by citations
Cited by
Sorted by citations
Pathogenesis of depression: Insights from human and rodent studies
Ménard, C., Hodes, G. E., & Russo, S. J. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2015.05.053 · Cited by 593
Inflammation, glutamate, and glia: a trio of trouble in mood disorders
Haroon, E., Miller, A. H., & Sanacora, G. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.199 · Cited by 584
Self-citationBelleau, E. L., Treadway, M. T., & Pizzagalli, D. A. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.09.031 · Cited by 550
Targeting glutamate signalling in depression: progress and prospects
Murrough, J. W., Abdallah, C. G., & Mathew, S. J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.16 · Cited by 482
Pan, Y., Chen, X.-Y., Zhang, Q.-Y., & Kong, L.-D. (2014) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2014.04.007 · Cited by 405
Kaster, M. P., Machado, N. J., Silva, H. B., Nunes, A., Ardais, A. P., Santana, M., Baqi, Y., Müller, C. E., Rodrigues, A. L. S., Porciúncula, L. O., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1423088112 · Cited by 312
Haroon, E., Fleischer, C. C., Felger, J. C., Chen, X., Woolwine, B. J., Patel, T., Hu, X. P., & Miller, A. H. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.206 · Cited by 250
Leng, L., Zhuang, K., Liu, Z., Huang, C., Gao, Y., Chen, G., Lin, H. Z., Hu, Y., Wu, D., Shi, M., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.08.031 · Cited by 238
Stratification of astrocytes in healthy and diseased brain
Verkhratsky, A., Zorec, R., & Parpura, V. (2017) · Brain Pathology · doi:10.1111/bpa.12537 · Cited by 236
Emerging mechanisms and treatments for depression beyond SSRIs and SNRIs
Dale, E., Bang‐Andersen, B., & Sánchez, C. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.03.011 · Cited by 247
An astroglial basis of major depressive disorder? An overview
Wang, Q., Jie, W., Liu, J., Yang, J., & Gao, T. (2017) · Glia · doi:10.1002/glia.23143 · Cited by 222
Abdallah, C. G., Sanacora, G., Duman, R. S., & Krystal, J. H. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.05.010 · Cited by 219
Self-citationBrain NMDA Receptors in Schizophrenia and Depression
Adell, A. (2020) · Biomolecules · doi:10.3390/biom10060947 · Cited by 225
Takahashi, K., Foster, J. B., & Lin, C. G. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1937-8 · Cited by 227
Glutamate Metabolism in Major Depressive Disorder
Abdallah, C. G., Jiang, L., De Feyter, H. M., Fasula, M., Krystal, J. H., Rothman, D. L., Mason, G. F., & Sanacora, G. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.14010067 · Cited by 200
Self-citationPsychiatric Disorders: Diagnosis to Therapy
Krystal, J. H., & State, M. W. (2014) · Cell · doi:10.1016/j.cell.2014.02.042 · Cited by 197
Depression as a Glial-Based Synaptic Dysfunction
Rial, D., Lemos, C., Pinheiro, H., Duarte, J. M., Gonçalves, F. Q., Real, J. I., Prediger, R. D., Gonçalves, N., Gomes, C. A., Canas, P. M., et al. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00521 · Cited by 193
The Neurobiology and Pharmacotherapy of Posttraumatic Stress Disorder
Abdallah, C. G., Averill, L. A., Akiki, T. J., Raza, M., Averill, C. L., Gomaa, H., Adikey, A., & Krystal, J. H. (2018) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010818-021701 · Cited by 179
Astrogliopathology in neurological, neurodevelopmental and psychiatric disorders
Verkhratsky, A., & Parpura, V. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.03.025 · Cited by 162
Neurobiology of resilience in depression: immune and vascular insights from human and animal studies
Dudek, K., Dion‐Albert, L., Kaufmann, F. N., Tuck, E., Lebel, M., & Ménard, C. (2019) · European Journal of Neuroscience · doi:10.1111/ejn.14547 · Cited by 168
Dale, E., Pehrson, A. L., Jeyarajah, T., Li, Y., Leiser, S. C., Smagin, G. N., Olsen, C. K., & Sánchez, C. (2015) · CNS Spectrums · doi:10.1017/s1092852915000425 · Cited by 156
Pehrson, A. L., & Sánchez, C. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s62912 · Cited by 150
Astroglial atrophy in Alzheimer’s disease
Verkhratsky, A., Rodriguez, J. J., Pivoriūnas, A., Zorec, R., & Semyanov, A. V. (2019) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-019-02310-2 · Cited by 150
Wright, D. J., Renoir, T., Smith, Z. M., Frazier, A. E., Francis, P. S., Thorburn, D. R., McGee, S. L., Hannan, A. J., & Gray, L. J. (2015) · Translational Psychiatry · doi:10.1038/tp.2014.131 · Cited by 137
Aiding and Abetting Anhedonia: Impact of Inflammation on the Brain and Pharmacological Implications
Lucido, M. J., Bekhbat, M., Goldsmith, D. R., Treadway, M. T., Haroon, E., Felger, J. C., & Miller, A. H. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000043 · Cited by 133
Disturbance of the Glutamatergic System in Mood Disorders
Jun, C. S., Choi, Y., Lim, S. M., Bae, S., Hong, Y. S., Kim, J. E., & Lyoo, I. K. (2014) · Experimental Neurobiology · doi:10.5607/en.2014.23.1.28 · Cited by 120
Translational potential of astrocytes in brain disorders
Verkhratsky, A., Steardo, L., Parpura, V., & Montana, V. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.09.003 · Cited by 115
Kynurenine regulates NLRP2 inflammasome in astrocytes and its implications in depression
Zhang, Q., Sun, Y., He, Z., Xu, Y. X., Li, X., Ding, J., Lu, M., & Hu, G. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.04.016 · Cited by 111
Curcumin in Depression: Potential Mechanisms of Action and Current Evidence—A Narrative Review
Ramaholimihaso, T., Bouazzaoui, F., & Kaladjian, A. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.572533 · Cited by 119
Freitas, A. E., Egea, J., Buendía, I., Gómez‐Rangel, V., Parada, E., Navarro, E., Casas, A. I., Wojnicz, A., Ortiz, J. A., Cuadrado, A., et al. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9182-6 · Cited by 108
Medina-Rodriguez, E. M., Lowell, J. A., Worthen, R. J., Syed, S. A., & Beurel, E. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00547 · Cited by 106
Faster, better, stronger: Towards new antidepressant therapeutic strategies
O’Leary, O. F., Dinan, T. G., & Cryan, J. F. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.07.046 · Cited by 104
Ernst, J., Hock, A., Henning, A., Seifritz, E., Boeker, H., & Grimm, S. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.73 · Cited by 97
Chronic Stress Alters Astrocyte Morphology in Mouse Prefrontal Cortex
Codeluppi-Arrowsmith, S. A., Chatterjee, D., Prévot, T. D., Bansal, Y., Misquitta, K. A., Sibille, E. L., & Banasr, M. (2021) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyab052 · Cited by 98
Self-citationAndoh-Noda, T., Akamatsu, W., Miyake, K., Matsumoto, T., Yamaguchi, R., Sanosaka, T., Okada, Y., Kobayashi, T., Ohyama, M., Nakashima, K., et al. (2015) · Molecular Brain · doi:10.1186/s13041-015-0121-2 · Cited by 92
Modulation of microglial activation by antidepressants
Mariani, N., Everson, J., Pariante, C. M., & Borsini, A. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811211069110 · Cited by 92
Janelidze, S., Suchankova, P., Ekman, A., Erhardt, S., Sellgren, C., Samuelsson, M., Westrin, A., Minthon, L., Hansson, O., Träskman‐Bendz, L., et al. (2015) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12339 · Cited by 86
Ketamine and other potential glutamate antidepressants
Dutta, A., McKie, S., & Deakin, J. F. W. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.10.028 · Cited by 92
Son, H., Baek, J. H., Go, B. S., Jung, D.-H., Sontakke, S. B., Chung, H. J., Lee, D. H., Roh, G. S., Kang, S. S., Cho, G. J., et al. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.09.040 · Cited by 89
Abdallah, C. G., Hannestad, J. O., Mason, G. F., Holmes, S. E., DellaGioia, N., Sanacora, G., Jiang, L., Matuskey, D., Satodiya, R. M., Gasparini, F., et al. (2017) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2017.03.019 · Cited by 84
Self-citationTaylor, R., Neufeld, R. W. J., Schaefer, B., Densmore, M., Rajakumar, N., Osuch, E. A., Williamson, P., & Théberge, J. (2015) · Schizophrenia · doi:10.1038/npjschz.2015.28 · Cited by 83
Inflammation-Associated Synaptic Alterations as Shared Threads in Depression and Multiple Sclerosis
Bruno, A., Dolcetti, E., Rizzo, F. R., Fresegna, D., Musella, A., Gentile, A., Vito, F. D., Caioli, S., Guadalupi, L., Bullitta, S., et al. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00169 · Cited by 87
Lazarevic, V., Yang, Y., Flais, I., & Svenningsson, P. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01246-3 · Cited by 81
Glutamatergic and neural dysfunction in postpartum depression using magnetic resonance spectroscopy
Rosa, C. E., Soares, J. C., de Figueiredo, F. P., Cavalli, R. D. C., Barbieri, M. A., Schaufelberger, M. S., Salmón, C. E. G., Del‐Ben, C. M., & dos Santos, A. C. (2017) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2017.04.008 · Cited by 81
Astrocyte regulation of synaptic signaling in psychiatric disorders
Kruyer, A., Kalivas, P. W., & Scofield, M. D. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01338-w · Cited by 83
Réus, G. Z., da Silva, R. H., de Moura, A. B., Presa, J. F., Abelaira, H. M., Abatti, M. R., Vieira, A. A. D. S., Pescador, B., Michels, M., Ignácio, Z. M., et al. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1161-2 · Cited by 82
Sarno, E., Moeser, A. J., & Robison, A. J. (2021) · Advances in pharmacology · doi:10.1016/bs.apha.2021.03.004 · Cited by 84
Kong, H., Zeng, X., Fan, Y., Yuan, S., Ge, S., Xie, W., Wang, H., & Hu, G. (2014) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12222 · Cited by 72
Role of adult hippocampal neurogenesis in the antidepressant actions of lactate
Carrard, A., Cassé, F., Carron, C., Burlet-Godinot, S., Toni, N., Magistretti, P. J., & Martin, J. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01122-0 · Cited by 74
Brockett, A. T., Kane, G. A., Monari, P. K., Briones, B. A., Vigneron, P.-A., Barber, G. A., Bermudez, A. F., Dieffenbach, U., Kloth, A. D., Buschman, T. J., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195726 · Cited by 75
Abdallah, C. G., Jackowski, A., Sato, J. R., Mao, X., Kang, G., Cheema, R., Coplan, J. D., Mathew, S. J., & Shungu, D. C. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.04.025 · Cited by 67
Novel rapid-acting glutamatergic modulators: Targeting the synaptic plasticity in depression
Wang, Y., Wang, X., Feng, S., Chen, N., Wang, Z., & Zhang, Y. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105761 · Cited by 68
Fullana, M. N., Ruiz‐Bronchal, E., Ferrés‐Coy, A., Juárez‐Escoto, E., Artigas, F., & Bortolozzi, A. A. (2019) · Glia · doi:10.1002/glia.23593 · Cited by 73
Banasr, M., Sanacora, G., & Esterlis, I. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.04.004 · Cited by 70
Self-citationRivera, A. D., & Butt, A. M. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0542-2 · Cited by 64
Antidepressants Impact Connexin 43 Channel Functions in Astrocytes
Jeanson, T., Pondaven, A., Ezan, P., Mouthon, F., Charvériat, M., & Giaume, C. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00495 · Cited by 64
Hertz, L., Rothman, D. L., Li, B., & Peng, L. (2015) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2015.00025 · Cited by 66
General Pathophysiology of Astroglia
Verkhratsky, A., Ho, M. S., Vardjan, N., Zorec, R., & Parpura, V. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-13-9913-8_7 · Cited by 66
Tsai, S., Hsu, P., Chen, Y., Hossain, M. S., Chen, P., Tzeng, S., Chen, P. S., & Kuo, Y. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01787-1 · Cited by 64
Astrocytes in functional recovery following central nervous system injuries
Alhadidi, Q., Bahader, G. A., Arvola, O., Kitchen, P., Shah, Z. A., & Salman, M. M. (2023) · The Journal of Physiology · doi:10.1113/jp284197 · Cited by 67
Retinal correlates of psychiatric disorders
Almonte, M. T., Capellàn, P., Yap, T. E., & Cordeiro, M. F. (2020) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622320905215 · Cited by 64
Abdallah, C. G., Niciu, M. J., Fenton, L. R., Fasula, M. K., Jiang, L., Black, A. C., Rothman, D. L., Mason, G. F., & Sanacora, G. (2014) · Psychotherapy and Psychosomatics · doi:10.1159/000361078 · Cited by 61
Self-citationLullau, A. P. M., Haga, E. M. W., Ronold, E. H., & Dwyer, G. E. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1223145 · Cited by 65
A New Outlook on Mental Illnesses: Glial Involvement Beyond the Glue
Elsayed, M., & Magistretti, P. J. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00468 · Cited by 62
Fluoxetine and all other SSRIs are 5-HT2B Agonists - Importance for their Therapeutic Effects
Peng, L., Gu, L., Li, B., & Hertz, L. (2014) · Current Neuropharmacology · doi:10.2174/1570159x12666140828221720 · Cited by 63
Fullana, M. N., Gasull-Camós, J., Tarrés-Gatius, M., Castañé, A., Bortolozzi, A. A., & Artigas, F. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107914 · Cited by 58
Contribution of neural cell death to depressive phenotypes of streptozotocin-induced diabetic mice
Chen, C., Wang, Y., Zhang, J., Ma, L., Gu, J., & Ho, G. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.016162 · Cited by 58
Zhu, X., Nedelcovych, M. T., Thomas, A. G., Hasegawa, Y., Moreno-Megui, A., Coomer, W., Vohra, V., Saito, A., Perez, G., Wu, Y., et al. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0177-7 · Cited by 53
Kōyama, Y. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00261 · Cited by 53
Yu, J.-Z., Wang, J. P., Sheridan, S. D., Perlis, R. H., & Rasenick, M. M. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0786-5 · Cited by 51
Pharmacotherapies Targeting GABA-Glutamate Neurotransmission for Treatment-Resistant Depression
Vecera, C. M., C. Courtes, A., Jones, G., Soares, J. C., & Machado-Vieira, R. (2023) · Pharmaceuticals · doi:10.3390/ph16111572 · Cited by 48
“Subjects with depression have been shown to display a variety of glutamatergic abnormalities, including reduced glial density, decreased expression of the glutamate reuptake transporters EAAT1 and EAAT2 and decreased enzymatic conversion from glutamate to glutamine [33].”
BackgroundInfluentialMokhtari, T., Yue, L., & Hu, L. (2023) · Scientific Reports · doi:10.1038/s41598-023-28418-1 · Cited by 48
RetractedMechanisms of action and clinical efficacy of NMDA receptor modulators in mood disorders
Ghasemi, M., Phillips, C., Fahimi, A., McNerney, M. W., & Salehi, A. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.07.002 · Cited by 53
Astrogliopathology in the infectious insults of the brain
Zorec, R., Avšič‐Županc, T., & Verkhratsky, A. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.08.003 · Cited by 45
Astrocytes in rapid ketamine antidepressant action
Stenovec, M., Li, B., Verkhratsky, A., & Zorec, R. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108158 · Cited by 52
Histone Modifications in Major Depressive Disorder and Related Rodent Models
Deussing, J. M., & Jakovcevski, M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-53889-1_9 · Cited by 46
Fullana, M. N., Covelo, A., Bortolozzi, A. A., Araque, A., & Artigas, F. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.09.004 · Cited by 46
Huang, Z., Davis Iv, H. H., Yue, Q., Wiebking, C., Duncan, N. W., Zhang, J., Wagner, N.-F., Wolff, A., & Northoff, G. (2015) · Human Brain Mapping · doi:10.1002/hbm.22841 · Cited by 43
Prefrontal cortex astroglia modulate anhedonia-like behavior
Codeluppi-Arrowsmith, S. A., Xu, M., Bansal, Y., Lepack, A. E., Duric, V., Chow, M., Muir, J., Bagot, R. C., Licznerski, P., Wilber, S. L., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02246-1 · Cited by 45
Self-citationDomin, H., Szewczyk, B., Woźniak, M., Wawrzak-Wleciał, A., & Śmiałowska, M. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.07.019 · Cited by 44
A Single Neurotoxic Dose of Methamphetamine Induces a Long-Lasting Depressive-Like Behaviour in Mice
Silva, C., Neves, A. F., Dias, A. I., de Freitas, H. J. F., Mendes, S. M., Pita, I. R., Viana, S., de Oliveira, P. A., Cunha, R. A., Ribeiro, C., et al. (2013) · Neurotoxicity Research · doi:10.1007/s12640-013-9423-2 · Cited by 43
Fujikawa, Y., Tominaga, K., Tanaka, F., Tanigawa, T., Watanabe, T., Fujiwara, Y., & Arakawa, T. (2015) · Neurogastroenterology & Motility · doi:10.1111/nmo.12577 · Cited by 43
Desipramine decreases expression of human and murine indoleamine-2,3-dioxygenases
Brooks, A. K., Janda, T. M., Lawson, M. A., Rytych, J. L., Smith, R. A. J., Ocampo-Solis, C., & McCusker, R. H. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.02.010 · Cited by 42
Sönmez, İ., Köşger, F., & Aykan, Ü. (2015) · Nöro Psikiyatri Arşivi · doi:10.5152/npa.2015.10115 · Cited by 45
Ketamine in Major Depressive Disorder: Mechanisms and Future Perspectives
Shin, C., & Kim, Y. (2020) · Psychiatry Investigation · doi:10.30773/pi.2019.0236 · Cited by 47
Roshan‐Milani, S., Seyyedabadi, B., Saboory, E., Parsamanesh, N., & Mehranfard, N. (2021) · Stress · doi:10.1080/10253890.2021.1942828 · Cited by 42
Yao, Z., Zhang, Z., Zhang, J., Cai, X., Zheng, Z., Huang, Y., & Qu, S. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.01.005 · Cited by 42
Chen, J.-X., Yao, L.-H., Xu, B.-B., Qian, K., Wang, H.-L., Liu, Z.-C., Wang, X.-P., & Wang, G.-H. (2014) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-014-1362-5 · Cited by 39
Sydnor, V. J., Sylvain Bouix, A., Pasternak, O., Härtl, E., Levin-Gleba, L., Reid, B. E., Tripodis, Y., Guenette, J. P., Kaufmann, D., Makris, N., et al. (2020) · NeuroImage Clinical · doi:10.1016/j.nicl.2020.102190 · Cited by 44
Human dermal fibroblasts in psychiatry research
Kalman, J. L., Garbett, K. A., Janka, Z., & Mirnics, K. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.01.067 · Cited by 45
Glial degeneration as a model of depression
Śmiałowska, M., Szewczyk, B., Woźniak, M., Wawrzak-Wleciał, A., & Domin, H. (2013) · Pharmacological Reports · doi:10.1016/s1734-1140(13)71518-4 · Cited by 39
The Role of Glutamine Homeostasis in Emotional and Cognitive Functions
Baek, J. H., Park, H., Kang, H., Kim, R., Kang, J. S., & Kim, H. J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021302 · Cited by 35
Connexin 43: An Interface Connecting Neuroinflammation to Depression
Jiang, H., Zhang, Y., Wang, Z., & Chen, N. (2023) · Molecules · doi:10.3390/molecules28041820 · Cited by 36
Multi-omics approach identifies gut microbiota variations associated with depression
Hernández-Cacho, A., García-Gavilán, J. F., Atzeni, A., Konstanti, P., Belzer, C., Vioqué, J., Corella, D., Fitó, M., Vidal, J., Mela, V., et al. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00707-9 · Cited by 38
Perez-Urrutia, N., Mendoza, C., Alvarez-Ricartes, N., Oliveros-Matus, P., Echeverria, F., Grizzell, J. A., Barreto, G. E., Iarkov, A., & Echeverría, V. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.06.016 · Cited by 38
Liu, R., Qu, H., Jun, X., Jian-xin, L., Qingyun, B., Yilin, C., & Haifeng, M. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.02.005 · Cited by 33
Singh, H., Wray, N. H., Schappi, J. M., & Rasenick, M. M. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0016-x · Cited by 34
RetractedBentea, E., Demuyser, T., Liefferinge, J. V., Albertini, G., Deneyer, L., Nys, J., Merckx, E., Michotte, Y. M., Sato, H., Arckens, L., et al. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.01.010 · Cited by 33
Wu, X., Chen, B., Di, Z., Jiang, S., Xu, H., Shi, M., Hu, R., Sun, S., Song, Z., Liu, J., et al. (2022) · BMC Neuroscience · doi:10.1186/s12868-022-00746-4 · Cited by 37
The lateral habenula and alcohol: Role of glutamate and M-type potassium channels
Shah, A., Zuo, W., Kang, S., Li, J., Fu, R., Zhang, H., Bekker, A., & Ye, J.-H. (2017) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2017.06.005 · Cited by 32
Metadata
- Authors
- Sanacora, G., & Banasr, M.
- Affiliations
- Yale University (US)
- Corresponding author
- Sanacora, Gerard
- Venue
- Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2013-06
- Volume
- 73
- Issue
- 12
- Pages
- 1172-1179
- ISSN
- 0006-3223 (ISSN-L)
- PMC
- PMC3688253
- OpenAlex
- W2077129553
- Cited by
- 239
- References
- 102
- Citations by year
- 2026: 13 · 2025: 10 · 2024: 14 · 2023: 17 · 2022: 17 · 2021: 22 · 2020: 15 · 2019: 20 · 2018: 21 · 2017: 18 · 2016: 17 · 2015: 27 · 2014: 24 · 2013: 4
- FWCI
- 3.03
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Biological Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Mental Health (R01MH085055, R01MH081211, R01 MH08055)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- glial cells, astrocytes, major depressive disorder, mood disorders, glutamate uptake, chronic stress, antidepressants, neuroinflammation
- MeSH terms
- Animals, Antidepressive Agents, Cell Communication, Humans, Neuroglia, Neurons, Mood Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review